LDN is an effective, safe and cost effective treatment which has been in active use for over 20 years on patients with autoimmune disorders. More and more evidence shows that LDN (3.0 – 4.5 mg taken orally at bedtime) promotes health supporting immune-modulation to reduce various oncogenic and inflammatory autoimmune processes. Since LDN upregulates endogenous opioid activity, it may also play a role in healing and repairing tissue. It may also promote stress resilience, exercise, social bonding & emotional well-being, as well as improve psychiatric problems like depression or autism.
LDN has been found to be an effective, highly tolerable, and inexpensive treatment to reduce daily pain in patients with fibromyalgia. LDN has demonstrated a reduction of daily pain reported by patients. The only major reported side effects are vivid dreams and headaches.
LDN can provide significant benefit for the pain management of patients with fibromyalgia, with minimal side effects and a high degree of tolerance.
A protocol utilizing LDN and intravenous alpha-lipoic acid (ALA/LDN) and a healthy lifestyle program has produced long-term survival without toxic side effects for patients with pancreatic cancer with or without metastases.
NOTE: We do not suggest that LDN be used in place of other treatment for cancer, but it may be a reasonable adjunctive therapy.